Related Experiment Videos
Venous thromboembolism.
1Division of Thoracic Diseases, Mayo Medical School, Rochester, MN 55905.
Postgraduate Medical Journal
|January 1, 1992
Summary
Pulmonary embolism (PE) is a deadly but preventable condition. Early diagnosis and treatment are crucial, alongside preventative measures like prophylaxis for high-risk individuals to reduce mortality.
Area of Science:
- Cardiology
- Pulmonology
- Vascular Medicine
Background:
- Pulmonary embolism (PE) is a significant cause of death and illness, often stemming from deep vein thrombosis (DVT).
- Despite being preventable and treatable, PE mortality in the U.S. exceeds that of AIDS.
- A high index of clinical suspicion is vital for identifying patients at risk for PE.
Purpose of the Study:
- To emphasize the importance of maintaining a high index of suspicion for pulmonary embolism in at-risk patients.
- To highlight the diagnostic challenges and necessary confirmatory studies for PE.
- To underscore the critical role of prevention and prophylaxis in managing deep vein thrombosis and pulmonary embolism.
Main Methods:
- Review of clinical suspicion, diagnostic imaging (ventilation-perfusion scans, pulmonary angiography), and treatment initiation criteria for pulmonary embolism.
- Discussion of the diagnostic accuracy of ventilation-perfusion scans in confirmed PE cases.
- Emphasis on preventative strategies, including prophylaxis for deep vein thrombosis.
Main Results:
- Only about one-third of patients suspected of having PE are ultimately diagnosed with it.
- A high-probability ventilation-perfusion scan is observed in only 40% of patients with angiographically proven PE.
- Indeterminate ventilation-perfusion scans should not be considered negative in cases of high clinical suspicion for PE.
Conclusions:
- Clinicians must confirm PE with appropriate diagnostic studies rather than relying solely on suspicion.
- Diagnostic protocols should account for the limitations of ventilation-perfusion scans, especially with high suspicion.
- Prophylaxis against deep vein thrombosis is essential for individuals at medium to high risk to prevent pulmonary embolism.